A United States-based Nigerian researcher, Oladele Ayomide Benjamen, has developed a low-cost artificial intelligence (AI) ...

BRAIN, an open-source AI scientist deploying three free computational tools to accelerate Alzheimer's drug discovery.

Women using progestogen contraceptives had a significantly increased risk of meningioma, the most common type of benign brain tumor. Consistent with other recent studies, injectable ...

A 60-year-old man in Spain went to the doctor complaining of a headache that he couldn’t shake. It had started two weeks prior and was only getting worse. He also said he had noticed subtle changes in ...

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%. The study, led ...

A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive ...

As the state investigates a possible cancer cluster at a high school, many Herald readers have asked whatever happened with the potential tumor cluster at a local hospital. Seven current and former ...

A new report on the investigation into a potential hospital cancer cluster is shedding light on the 11 nurses who were diagnosed with brain tumors. Eleven current and former nurses in Newton-Wellesley ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...

Illustration of a high-resolution brain tractogram, depicting the complex network of neural pathways in the human brain. The intricate fibre tracts are visualised using advanced diffusion tensor ...

Brain tumors are one of the most devastating consequences of cancer’s spread—hard to treat and highly deadly. Scientists have found that using a radioactive implant precisely where a tumor was removed ...

Integrating tumor mutation profiles, preoperative circulating tumor DNA (ctDNA), and clinical features to a predicting model for early peritoneal recurrence in stage II-III gastric cancer following ...